Mapping the immune environment in clear cell renal carcinoma by single-cell genomics

Area of Science:

• Immunology
• Oncology
• Genomics

Background:

• Clear cell renal cell carcinoma (ccRCC) exhibits unique immunological characteristics and high immunotherapy response rates, despite a low tumor mutational burden.
• Understanding the tumor immune microenvironment (TME) is crucial for ccRCC, particularly given its distinct immune profile.

Purpose of the Study:

• To characterize the transcriptomic heterogeneity of immune cells within the ccRCC tumor microenvironment.
• To identify specific immune cell subpopulations and their roles in ccRCC progression and clinical outcomes.

Main Methods:

• Single-cell RNA sequencing (scRNA-seq) and T-cell receptor (TCR) sequencing were applied to analyze 25,688 CD45+ immune cells from ccRCC tumors and blood.
• Comparative analysis included 11,367 immune cells from normal kidney and peripheral blood to identify ccRCC-specific immune cell differences.

Main Results:

• Tumor-infiltrating immune cells showed increased CD8+ T-cell and macrophage populations compared to normal renal tissue.
• Divergent transcriptional states were identified in tumor-infiltrating CD8+ T cells, including a MKI67+ proliferative subpopulation linked to ccRCC progression.
• scRNA-seq gene expression data enabled preferential prediction of clinical outcomes and pathological features by immune cell subcluster assignment.

Conclusions:

• The study identified distinct immune cell subpopulations within the ccRCC TME, including a potentially oncogenic CD8+ T-cell subset.
• These findings highlight specific immune cell populations that may be targeted for therapeutic intervention in ccRCC.
• Further research and functional validation are warranted to explore the therapeutic potential of identified immune cell subpopulations.